Dr. Nathaniel James Rhodes leads a research lab focused on the development of Precision Dosing strategies for antibiotic treatment in patients suffering from severe pneumonia caused by antibiotic-resistant bacteria. The lab uses innovative pharmacokinetic (PK) models to optimize beta-lactam antibiotic dosing, aiming to improve patient outcomes and reduce treatment failures. Through this work, the lab addresses critical public health challenges associated with antibiotic resistance.